Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (241-250 of 441) with videos related to

Pageof 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancerG Thomas Budd, Massimo Cristofanilli, Mathew J Ellis, et al.
The New England Journal of Medicine|June 2, 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast CancerNicholas C Turner, Jungsil Ro, Fabrice André, et al.
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
RSC Advances|November 3, 2017
Precision Microfilters as an all in one System for Multiplex Analysis of Circulating Tumor CellsDaniel L Adams, R Katherine Alpaugh, Stuart S Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancerMassimo Cristofanilli, Vicente Valero, Aroop Mangalik, et al.
Cancer Discovery|September 13, 2018
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 TrialBen O'Leary, Rosalind J Cutts, Yuan Liu, et al.
Oncotarget|February 7, 2022
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancersAmi N Shah, Ashwin Sunderraj, Brian Finkelman, et al.
The Oncologist|February 5, 2008
Prognostic value of initial clinical disease stage after achieving pathological complete responseShaheenah Dawood, Kristine Broglio, Shu-Wan Kau, et al.
Breast Cancer Research and Treatment|November 18, 2015
Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancerZhaomei Mu, Chun Wang, Zhong Ye, et al.
BMC Cancer|June 20, 2019
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancerTim N Beck, Yanis A Boumber, Charu Aggarwal, et al.
Pageof 45

Showing results (241-250 of 441) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancerG Thomas Budd, Massimo Cristofanilli, Mathew J Ellis, et al.
The New England Journal of Medicine|June 2, 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast CancerNicholas C Turner, Jungsil Ro, Fabrice André, et al.
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
RSC Advances|November 3, 2017
Precision Microfilters as an all in one System for Multiplex Analysis of Circulating Tumor CellsDaniel L Adams, R Katherine Alpaugh, Stuart S Martin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancerMassimo Cristofanilli, Vicente Valero, Aroop Mangalik, et al.
Cancer Discovery|September 13, 2018
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 TrialBen O'Leary, Rosalind J Cutts, Yuan Liu, et al.
Oncotarget|February 7, 2022
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancersAmi N Shah, Ashwin Sunderraj, Brian Finkelman, et al.
The Oncologist|February 5, 2008
Prognostic value of initial clinical disease stage after achieving pathological complete responseShaheenah Dawood, Kristine Broglio, Shu-Wan Kau, et al.
Breast Cancer Research and Treatment|November 18, 2015
Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancerZhaomei Mu, Chun Wang, Zhong Ye, et al.
BMC Cancer|June 20, 2019
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancerTim N Beck, Yanis A Boumber, Charu Aggarwal, et al.
Pageof 45